Key result
In patients with acute coronary syndrome, elevated C-reactive protein levels (≥22 mg/L) were associated with a higher 30-day mortality rate (19.7%) compared to levels <22 mg/L (6.5%).
Why the study?
Does elevated C-reactive protein (≥ 22 mg/L) correlate with increased 30-day mortality in patients presenting with acute coronary syndrome?
Observational (n=250)
No
Does elevated C-reactive protein (≥ 22 mg/L) correlate with increased 30-day mortality in patients presenting with acute coronary syndrome?
Absolute Event Rate: 19.7% vs 6.5%
Elevated C-reactive protein levels (≥ 22 mg/L) at presentation are associated with a significantly higher risk of 30-day mortality in patients with acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Elevated CRP may aid short-term risk stratification in ACS; this observational association leaves open causality and need for intervention trials.
Maqbool et al. (2017) conducted an observational in Acute coronary syndrome (n=250). Elevated C-reactive protein (≥22 mg/L) vs. C-reactive protein <22 mg/L was evaluated on 30-day mortality. In patients with acute coronary syndrome, elevated C-reactive protein levels (≥22 mg/L) were associated with a higher 30-day mortality rate (19.7%) compared to levels <22 mg/L (6.5%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: